Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomized controlled trial. - Dormandy,JA.; Chabonnel,B.; Eckland,DJ.; Erdmann,E.; Massi-Benedetti,M.; Moules,IK.; Skene,AM.; Tan,MH.; Lefebvre,PJ.; Murray,GD.; Standl,E.; Wilcox,RG.; et al. (Lancet, 2005)